Jon M. Plexico
@Stonepine Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$158.248MTotal holdings38
Assets growth rate44.39%Assets growth rate (2-Q avg)15.67%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Stonepine Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Stonepine Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 158.248M in assets, with a quarterly growth rate of 44.39% and a 2-quarter average growth rate of 15.67%. The portfolio is managed by Jon M. Plexico, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RIGLRigel Pharmaceuticals Inc
| 3.17% | $5.001M 309,100 shares@ $16.18 avg price | Increased 1.35% |
ANIKAnika Therapeutics Inc
| 2.96% | $4.676M 189,308 shares@ $24.71 avg price | Increased 14.46% |
IRWDIronwood Pharmaceuticals Inc
| 2.61% | $4.12M 1M shares@ $4.12 avg price | Increased 1982.82% |
OPTNOptinose Inc
| 2.41% | $3.811M 5.689M shares@ $0.67 avg price | Increased 142.07% |
SCPHScpharmaceuticals Inc
| 2.25% | $3.552M 778,874 shares@ $4.56 avg price | Increased 84.7% |
ACADAcadia Pharmaceuticals Inc
| 1.92% | $3.028M 196,895 shares@ $15.38 avg price | Increased 3837.9% |
ACRSAclaris Therapeutics Inc
| 1.79% | $2.828M 2.459M shares@ $1.16 avg price | Increased 27.58% |
TELATela Bio Inc
| 1.78% | $2.808M 1.11M shares@ $2.53 avg price | Increased 77.42% |
XGNExagen Inc
| 1.05% | $1.651M 534,398 shares@ $3.1 avg price | Increased 48.99% |
SRZNSurrozen Inc
| 0.84% | $1.318M 110,000 shares@ $11.98 avg price | Increased 66.46% |